WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: APRIL ISSUE PUBLISHED
  • April Issue has been successfully launched on 1 April 2024.

Abstract

CLINICAL EFFICACY OF AYURVEDIC FORMULATION APAMARGA KSHARA AND VIRECHANA CHURNA IN TAMAKA SWASA (BRONCHIAL ASTHMA)

Chhajer Arun*, Pandey Poornima and Tripathi R.N.

ABSTRACT

Tamaka Swasa is a disease described in the ayurvedic text that shows close resembles with Bronchial Asthma on the basis of clinical manifestation. Ayurvedic text contributes several type of treatment for Tamaka Swasa. Study was carried out in 60 patients of either sex in between the age of 18-60 years to assure the clinical response of Apamarga kshara in Bronchial Asthma. Ayurved offer promising results in the management of Tamaka Swasa through a set of treatment motilities. Shodhana and shamana are some of such motilities. Virechana is established as shodhana treatment for Tamaka Swasa. In the study design group A is treated with Apamarga Kshara and group B is treated with Apamarga Kshara and Virechana churna. On the assessment, it is observed that the effect of Apamarga Kshara in Tamaka Swasa is highly significant i.e. p < 0.01% on the basis of subjective parameters (Night awakening, morning worsening, limitation of activity, shortness of breath, wheeze etc.) and objective parameter (Hb%, AEC, ESR, BHT, PEFR, FEV1, FVC). The drug is quite safe and act as bronchodilator, anti histaminic and anti inflammatory.

Keywords: Tamaka Swasa, Bronchial Asthma, Apamarga Kshara, Virechana churna, BHT (Breath holding time), PEFR (Peak expiratory flow rate), FEV1(Force expiratory volume in first second ), FVC (Force vital capacity).


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More